Related party transactions

3 Months Ended

Mar. 31, 2017

Related party transactions

Related party transactions

11. Related‑Party Transactions

During the three months ended March 31, 2017 and March 31, 2016, the Company received consulting and management services from one of its investors. The total amount of consulting and management services provided by this investor was approximately $10.0 thousand during the three months ended March 31, 2017. The total amount of services provided by this investor was approximately $3.0 thousand during the months ended March 31, 2016. As of March 31, 2017, the Company did not have a balance in accounts payable related to consulting and management service fees charged by this investor.

During the three months ended March 31, 2017, the Company recognized $1.5 million of revenue associated with the Collaboration Agreement related to research and development services provided during this period. During the three months ended March 31, 2016, the Company recognized $4.8 million of revenue associated with the Collaboration Agreement related to research and development services provided during the period. The Company also recognized $43.8 thousand of expense during the three months ended March 31, 2017, related to in‑kind services provided by Genzyme associated with the Collaboration Agreement. The Company recognized $0.5 million of expense during the three months ended March 31, 2016, related to in-kind services provided by Genzyme under the Collaboration Agreement.